Preferred Label : Nivolumab and Recombinant Human Hyaluronidase Regimen;
NCIt synonyms : Nivolumab and Hyaluronidase-nvhy Regimen; Opdivo Qvantig Regimen; Nivolumab/Hyaluronidase-nvhy Regimen;
NCIt definition : A regimen consisting of nivolumab and recombinant human hyaluronidase that can be
used in the treatment of ampullary, appendiceal, and small bowel adenocarcinoma, Merkel
cell carcinoma, Kaposi sarcoma, peritoneal and pleural mesothelioma, cutaneous and
uveal melanoma, endometrial carcinoma, central nervous system (CNS) cancer, non-small
cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma,
anal, bladder, biliary tract, colorectal, esophageal, head and neck, thyroid cancer,
cervical, kidney, squamous cell skin, vulvar, and vaginal cancer, gestational trophoblastic
neoplasia, and well-differentiated grade 3 neuroendocrine tumors (NETs).;
Origin ID : C213204;
chemotherapy_regimen_has_component
- concept_is_in_subset
